Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-08-25, Stock:JNJ, The news for the past five days is as follows:
2020-08-18: NEWS1: Report: States Pushing for $26.4 Billion Settlement With Drug Companies Over Opioid Liability.NEWS2: Johnson & Johnson stock outperforms market on strong trading day.NEWS3: EXPLAINER-World Health Organization's struggle for a global COVID-19 vaccine plan.NEWS4: Drug-Distributor Stocks Rise as Opioid Settlement Looks Closer After Report on More Talks.NEWS5: Brazil greenlights human trials for J&J's potential COVID-19 vaccine.NEWS6: Brazil approves human trials for potential Johnson & Johnson COVID-19 vaccine.NEWS7: U.S. states seek $26.4 bln from drug firms in opioid litigation - WSJ.
2020-08-19: NEWS1: SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Momenta Pharmaceuticals, Inc. (Nasdaq - MNTA).NEWS2: SHAREHOLDER ALERT: WeissLaw LLP Investigates Momenta Pharmaceuticals, Inc..NEWS3: Nasdaq Falls Off Record Levels; Momenta, BioMarin Head in Opposite Directions.NEWS4: Johnson & Johnson stock outperforms market on strong trading day.NEWS5: Why Momenta Pharmaceuticals Stock Rocketed 69% Higher Today.NEWS6: Johnson & Johnson to Acquire Momenta Pharmaceuticals for $6.5 Billion in Cash.NEWS7: US STOCKS-S&P 500, Nasdaq hit record highs as Apple crosses $2 trillion mark.NEWS8: Could Momenta Deal Give Johnson & Johnson Breakout Momentum?.NEWS9: MOMENTA PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout.NEWS10: Dow Jones Up As Apple Stock Makes History; S&P 500, Nasdaq Hit New Highs.NEWS11: Looking Into Johnson & Johnson's Return On Capital Employed.NEWS12: US STOCKS-S&P 500, Nasdaq hit record highs as Apple tops $2 trillion in market value.NEWS13: Johnson & Johnson -- Moody's affirms J&J's Aaa rating; negative outlook.NEWS14: Johnson & Johnson Is Buying Momenta Pharmaceuticals. Both Stocks Are Gaining..NEWS15: Stocks move modestly higher, S&P 500 clinches new intraday high.NEWS16: P/E Ratio Insights for Johnson & Johnson.NEWS17: US STOCKS-S&P 500 notches record high for second day after Target, Lowe's results beat.NEWS18: Johnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 Billion.NEWS19: J&J $6.5 Billion Momenta Pact Is Year’s Biggest Pharma Deal.NEWS20: Johnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 Billion; Buy with Target Price $170.NEWS21: Johnson & Johnson Buys Biotech Momenta Pharmaceuticals for $6.5 Billion.NEWS22: US STOCKS-Wall St set to open higher after solid results from Lowe's, Target.NEWS23: Johnson & Johnson's Debt Overview.NEWS24: J&J strikes $6.5 billion deal for autoimmune disease specialist Momenta.NEWS25: (MNTA) Alert: Johnson Fistel Investigates Proposed Sale of Momenta Pharmaceuticals; Are Shareholders Getting a Fair Price?.NEWS26: JNJ To Buy Momenta Pharma In $6.5B All-Cash Deal; MNTA Up 70%.NEWS27: Don't Buy Johnson & Johnson (NYSE:JNJ) For Its Next Dividend Without Doing These Checks.NEWS28: Momenta Pharmaceuticals' stock rockets after $6.5 billion buyout deal with Johnson & Johnson.NEWS29: J&J strikes $6.5 billion deal for autoimmune disease specialist Momenta.NEWS30: Johnson & Johnson to buy Momenta for about $6.5 billion.NEWS31: Johnson & Johnson to buy Momenta for about $6.5 bln.NEWS32: Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases.NEWS33: PRESS DIGEST - Wall Street Journal - Aug. 19.
2020-08-20: NEWS1: J&J Borrows $7.5 Billion for Momenta in Latest M&A Bond Sale.NEWS2: Johnson & Johnson to Launch Late-Stage Coronavirus Vaccine Trials in September.NEWS3: Johnson & Johnson stock rises Thursday, outperforms market.NEWS4: Johnson & Johnson Sets Late-Stage Vaccine Trial Next Month.NEWS5: Coronavirus Latest: Thursday, August 20.NEWS6: ETFs in Focus on Momenta Buyout Deal With JNJ.NEWS7: Johnson & Johnson to test coronavirus vaccine in 60,000 volunteers.NEWS8: J&J to Buy Momenta for $6.5B to Boost Autoimmune Presence.NEWS9: Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of the Champions of Science® Initiative.NEWS10: CureVac Stock Up as EU Talks on Coronavirus Vaccine Advance.NEWS11: 2 Big Pharma Stocks That Robinhood Investors Really Like -- and You Should, Too.
2020-08-21: NEWS1: Tech, Tesla, and Apple Star as Stocks Keep Rising.NEWS2: Johnson & Johnson stock rises Friday, outperforms market.NEWS3: Apple Inc., Nike share gains lead Dow's 215-point climb.NEWS4: Pennant Investors Trims Johnson & Johnson, Microsoft.NEWS5: 7 Safe Stocks to Buy That Can Shrug Off the Growing Volatility.NEWS6: Pfizer, Johnson & Johnson take steps forward with vaccine trials.NEWS7: Eli Lilly (Still) Looks Like the Best Buy in Large-Cap Pharma.NEWS8: Ex-FDA Commissioner Analyzes Johnson & Johnson's Mega Vaccine Trial.NEWS9: Pfizer Eyes Vaccine Race Finish Line.NEWS10: Tesla Stock Is Unstoppable.NEWS11:  We need Multiple vaccines to be successful: Dr. Dan Barouch.NEWS12: American Airlines Cuts Flights to 15 Cities, and Two More Numbers to Know.NEWS13: JNJ Seeking 60,000 Participants For Massive Covid-19 Vaccine Trial.NEWS14: JNJ’s Darzalex Scores FDA Nod For Multiple Myeloma Treatment.NEWS15: Stocks - Deere, Biontech and Foot Locker Rise Premarket.NEWS16: Johnson & Johnson Borrows $7.5B To Fund Its Purchase Of Momenta.NEWS17: Johnson & Johnson adds to debt frenzy, borrows $7.5 billion to buy Momenta.
2020-08-24: NEWS1: S&P 500, Nasdaq Hit Record Highs As Several Leaders Near Buy Points.NEWS2: Johnson & Johnson stock rises Monday, still underperforms market.NEWS3: Coronavirus update: FDA authorizes convalescent plasma, spurring concerns over vaccine approvals.NEWS4: Second-Quarter Dividends Plunged 22%, the Biggest Drop Since 2009.NEWS5: Pharma Rivals Are Fighting Covid Together. Why Stop There?.NEWS6: Global Stock Dividends Fell 22% in the Second Quarter. Here’s Where the Worst Declines Happened..NEWS7: Is Johnson & Johnson A Better Healthcare Play Than Pfizer?.

Answer: Decrease